FNY Managed Accounts’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-72
Closed -$3K 614
2017
Q4
$3K Buy
+72
New +$3.31K ﹤0.01% 379
2017
Q3
Sell
-373
Closed -$14K 608
2017
Q2
$14K Sell
373
-74
-17% -$2.8K 0.14% 105
2017
Q1
$17K Buy
+447
New +$17.4K 0.05% 374

Other funds holding AVNS

FNY Managed Accounts's AVNS Position: Q1 2018 in Review

FNY Managed Accounts sold out of Avanos Medical (AVNS) in Q1 2018, closing a stake of 72 shares — an estimated $3K sold.

FNY Managed Accounts first reported a position in AVNS in Q1 2017 and held it in 3 quarters. The position peaked at $17K in Q1 2017. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2018.

  • FNY Managed Accounts reported no remaining Avanos Medical position as of Q1 2018 after selling out during the quarter.
  • FNY Managed Accounts sold 72 Avanos Medical shares in Q1 2018, an estimated $3K.
  • FNY Managed Accounts first reported a position in Avanos Medical in Q1 2017 and held it in 3 quarters.
  • FNY Managed Accounts's Avanos Medical position peaked at $17K in Q1 2017.
  • 338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.